by Peter Ciszewski | Jan 31, 2018
Alisa Shakarian of Cambridge Biomarketing discusses some of the trends in the rare disease industry, including the use of social media and patient empowerment.
by Peter Ciszewski | Jan 31, 2018
Jean Tang, MD, PhD is co-founder of PellePharm and serves on the PellePharm board of directors. She is a practicing dermatologist and associate professor of dermatology at Stanford University. In this video, Dr. Tang discusses Gorlin Syndrome, a rare, genetic, disease...
by Peter Ciszewski | Jan 31, 2018
Sanuj K. Ravindran, MD is president and CEO of PellePharm. Dr. Ravindran also serves on the PellePharm Board of Directors, and is CEO-in-Residence with BridgeBio, PellePharm’s parent company.
by Peter Ciszewski | Jan 24, 2018
The American Thyroid Association has estimated that about 20 million U.S citizens have some thyroid disorder. In addition to this, up to 60% of these people do not know that they have the condition. Also, women are 8 times more likely to have this disease than men....
by Peter Ciszewski | Jan 23, 2018
Sanuj K. Ravindran, MD is president and CEO of PellePharm. Dr. Ravindran also serves on the PellePharm Board of Directors, and is CEO-in-Residence with BridgeBio, PellePharm’s parent company. PellePharm is a biotechnology company committed to targeting rare...
